Fiduciary Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$154K 211
2024
Q4
$154K Buy
+200
New +$166K 0.05% 62

Other funds holding LLY

Fiduciary Family Office's LLY Position: Q2 2026 in Review

Fiduciary Family Office increased its Eli Lilly (LLY) stake by 0.81% in Q2 2026, buying an estimated $50.1K and bringing the position to 6,119 shares worth $7.34M. The position accounts for 1.84% of the portfolio, ranked #8.

Fiduciary Family Office first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fiduciary Family Office held 6,119 shares of Eli Lilly worth $7.34M as of Q2 2026.
  • Fiduciary Family Office bought 49 Eli Lilly shares in Q2 2026, an estimated $50.1K.
  • Eli Lilly made up 1.84% of Fiduciary Family Office's portfolio in Q2 2026, its #8 holding.
  • Fiduciary Family Office first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.